TOPIC
Serum Institute of India
Adar Poonawalla’s factory was gheraod by Shiv Sena goons demanding that they be given the vaccine first: Rahul Kanwal
CEO of the Serum Institute of India Adar Poonawalla has temporarily moved out after facing threats from the most powerful men in India
Adar Poonawalla says Covishied production is in full swing, will return to India in a few days after meeting in UK
Adar Poonawalla shared the latest update on his meeting with the stakeholders in the UK and production of Covishield.
Serum Institute CEO Adar Poonawalla hints at starting vaccine production outside India, says he temporarily moved to UK due to threats from the powerful
Adar Poonawalla said Serum Institute will start vaccine production in other countries as it struggles to meet supply commitments
Bharat Biotech reduces the price of Covaxin for state governments a day after Covishield price for states cut by SII
Bharat Biotech has announced that it is reducing the price of its Covid-19 vaccine Covaxin for the state governments to Rs 400 from Rs 600
Adar Poonawalla announces reduction in Covishield vaccine price, will be available for state govts for Rs 300 per dose
Terming it as a philanthropic move, Poonawalla informed the price of Covishield has been slashed to Rs 300/ dose for the states effective immediately.
After massive criticism and NSA-level talks, USA lifts export ban over vaccine raw material needed by SII
The US govt has finally decided to lift the embargo over the critical raw material and send them for manufacture of Covishield at the earliest.
Congress party continues propaganda against Indian vaccine makers, invents another fake scam to allege they will earn more profit than Reliance Industries
Congress claimed that Serum Institute and Bharat Biotech will earn ₹1,11,100 crore from vaccine sale, almost 4 times of Reliance profit
UP govt places order for 1 crore doses of vaccines from Serum Institute and Bharat Biotech for phase 3 vaccination drive
UP govt has ordered 50 lakh doses each of Covaxin and Covishield vaccines from Bharat Biotech and Serum Institute of India
Bharat Biotech announces Covaxin prices for state governments and private hospitals for Phase 3 of Covid-19 vaccination program
Bharat Biotech said that Covaxin price for the state governments will be ₹600, and the price for private hospitals will be ₹1200
‘Most affordable vaccine today’: SII CEO Adar Poonawalla issues clarification over Covishield costs after opposition parties cry foul
SII CEO Adar Poonawalla has issued a statement to address the controversy regarding the cost of Covishield.
